4.7 Review

The role of vasoactive peptides in skin homeostasis-focus on adiponectin and the kallikrein-kinin system

Journal

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
Volume 324, Issue 3, Pages C741-C756

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpcell.00269.2022

Keywords

adiponectin; bradykinin; skin; vasoactive peptides

Ask authors/readers for more resources

This article reviews the role of two vasoactive peptides, adiponectin and bradykinin, in skin homeostasis. Adiponectin, mainly found in fat depots, can exert paracrine effects in various skin cells. The potential involvement of adiponectin in skin disorders such as psoriasis, atopic dermatitis, and melanogenesis is discussed. The kallikrein-kinin system, including bradykinin, is also found expressed in the skin and may contribute to wound healing, psoriasis, and melanoma.
Vasoactive peptides often serve a multitude of functions aside from their direct effects on vasodynamics. This article will review the existing literature on two vasoactive peptides and their involvement in skin homeostasis: adiponectin and-as the main representative of the kallikrein-kinin system-bradykinin. Adiponectin is the most abundantly expressed adipokine in the human organism, where it is mainly localized in fat depots including subcutaneous adipose tissue, from where adiponectin can exert paracrine effects. The involvement of adiponectin in skin homeostasis is supported by a number of studies reporting the effects of adiponectin in isolated human keratinocytes, sebocytes, fibroblasts, melanocytes, and immune cells. Regarding skin pathology, the potential involvement of adiponectin in psoriasis, atopic dermatitis, scleroderma, keloid, and melanogenesis is discussed in this article. The kallikrein-kinin system is composed of a variety of enzymes and peptides, most of which have been identified to be expressed in the skin. This also includes the expression of bradykinin receptors on most skin cells. Bradykinin is one of the very few hormones that is targeted by treatment in routine clinical use in dermatology-in this case for the treatment of hereditary angioedema. The potential involvement of bradykinin in wound healing, psoriasis, and melanoma is further discussed in this article. This review concludes with a call for additional preclinical and clinical studies to further explore the therapeutic potential of adiponectin supplementation (for psoriasis, atopic dermatitis, wound healing, scleroderma, and keloid) or pharmacological interference with the kallikrein-kinin system (for wound healing, psoriasis, and melanoma).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available